Qualitative and quantitative effects of CD28/B7-mediated costimulation on naive T cells in vitro

Journal of Immunology

Volumn 161, Issue 8, 1998, Pages 3827-3835

  Manickasingham, Shivanthi P ^a   Anderton, Stephen M ^a   Burkhart, Christoph ^a   Wraith, David C ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; B7 ANTIGEN; CD28 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MYELIN BASIC PROTEIN; T LYMPHOCYTE RECEPTOR; TYROSINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN PRESENTING CELL; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FLOW CYTOMETRY; HELPER CELL; LYMPHOCYTE DIFFERENTIATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL; T LYMPHOCYTE ACTIVATION; TRANSGENIC MOUSE;

ANIMALS; ANTIGENS, CD28; ANTIGENS, CD80; CELLS, CULTURED; INTERFERON TYPE II; INTERLEUKIN-2; INTERLEUKIN-5; LYMPHOCYTE ACTIVATION; MICE; MYELIN BASIC PROTEINS; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; T-LYMPHOCYTES;

EID: 0032532321     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Linsley, P. S., and J. A. Ledbetter. 1993. The role of the CD28 receptor during T-cell responses to antigen. Annu. Rev. Immunol. 11:191.
2. Schwartz, R. H. 1989. A cell culture model for T-cell clonal anergy. Cold Spring Harbor Symp. Quant. Biol. 54:605.
3. Das, M. R. P., S. S. Zamvil, F. Borriello, H. L. Weiner, A. H. Sharpe, and V. K. Kuchroo. 1995. Reciprocal expression of costimulatory molecules, B7-1 and B7-2, on murine T-cells following activation. Eur. J. Immunol. 25:207.
4. Linsley, P., W. Brady, M. Urner, L. S. Grosmaire, N. K. Damle, and J. A. Ledbetter. 1991. CTLA-4 is a second receptor for the B-cell activation antigen B7. J. Exp. Med. 174:561.
5. Walunas, T. L., D. L. Lenschow, C. Y. Baker, P. S. Linsley, G. J. Freeman, J. M. Green, C. B. Thompson, and J. A. Bluestone. 1994. CTLA-4 can function as a negative regulator of T cell function. Immunity 1:405.
6. Kirk, A. D., D. M. Harlan, N. N. Armstrong, T. A. Davis, Y. C. Dong, G. S. Gray, X. N. Hong, D. Thomas, J. H. Fechner, and S. J. Knechtle. 1997. CTLA4-Ig and anti-CD4O ligand prevent renal allograft rejection in primates. Proc. Natl. Acad. Sci. USA 94:8789.
7. Chambers, C. A., D. Cado, T. Truong, and J. P. Allison. 1997. Thymocyte development is normal in CTLA-4-deficient mice. Proc. Natl. Acad. Sci. USA 94: 9296.
8. Daikh, D., D. Wofsy, and J. B. Imboden. 1997. The CD28-B7 costimulatory pathway and its role in autoimmune disease. J. Leukocyte Biol. 62:156.
9. Lenschow, D. J., K. C. Herold, L. Rhee, B. Patel, A. Koons, H. Y. Qin, E. Fuchs, B. Singh, C. B. Thompson, and J. A. Bluestone. 1996. CD28/B7 Regulation of Th1 and Th2 subsets in the development of autoimmune diabetes. Immunity 5:285.
10. Shahinian, A., K. Pfeffer, K. P. Lee, T. M. Kundig, K. Kishihara, A. Wakeham, K. Kawai, P. S. Ohashi, C. B. Thompson, and T. W. Mak. 1993. Differential T-cell costimulatory requirements in CD28-deficient mice. Science 261:609.
11. Keane-Myers, A., W. C. Gause, P. S. Linsley, S. J. Chen, and M. Wills-Karp. 1997. B7-CD28/CTLA-4 costimulatory pathways are required for the development of T helper cell 2-mediated allergic airway responses to inhaled antigens. J. Immunol. 158:2042.
12. Schweitzer, A. N., F. Borriello, R. C. K. Wong, A. K. Abbas, and A. H. Sharpe. 1997. Role of costimulators in T cell differentiation: studies using antigen-presenting cells lacking expression of CD80 or CD86. J. Immunol. 158:2713.
13. Ranger, A. M., M. P. Das, V. K. Kuchroo, and L. H. Glimcher. 1996. B7-2 (CD86) is essential for the development of IL-4-producing T-cells. Int. Immunol. 8:1549.
14. Mossmann, T. R., and R. L. Coffman. 1987. Two types of mouse helper T-cell clone-implications for immune regulation. Immunol. Today 8:223.
15. Mosmann, T. R., and R. L. Coffman. 1989. Th1-cell and Th2-cell: different patterns of lymphokine secretion lead to different functional properties. Annu. Rev. Immunol. 7:145.
16. + T-cells. Annu. Rev. Immunol. 12:635.
17. Freeman, G. J., J. G. Gribben, V. A. Boussiotis, J. W. Ng, V. A. Restivo, L. A. Lombard, G. S. Gray, and L. M. Nadler. 1993. Cloning of B7-2: a CTLA-4 counter-receptor that costimulates human T-cell proliferation. Science 262:909.
18. Hathcock, K. S., G. Laszlo, C. Pucillo, P. Linsley, and R. J. Hodes. 1994. Comparative-analysis of B7-1 and B7-2 costimulatory ligands expression and function. J. Exp. Med. 180:631.
19. Lenschow, D. J., A. I. Sperling, M. P. Cooke, G. Freeman, L. Rhee, D. C. Decker, G. Gray, L. M. Nadler, C. C. Goodnow, and J. A. Bluestone. 1994. Differential up-regulation of the B7-1 and B7-2 costimulatory molecules after Ig receptor engagement by antigen. J. Immunol. 153:1990.
20. Kuchroo, V. K., M. P. Das, J. A. Brown, A. M. Ranger, S. S. Zamvil, R. A. Sobel, H. L. Weiner, N. Nabavi, and L. H. Glimcher. 1995. B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: application to autoimmune-disease therapy. Cell 80:707.
21. Lenschow, D. J., S. C. Ho, H. Sattar, I. Rhee, G. Gray, N. Nabavi, K. C. Herold, and J. A. Bluestone. 1995. Differential-effects of anti-B7-1 and anti-B7-2 monoclonal-antibody treatment on the development of diabetes in the nonobese diabetic mouse. J. Exp. Med. 181:1145.
22. Fugger, L., J. Liang, A. Gautam, J. B. Rothbard, and H. O. Mcdevitt. 1996. Quantitative-analysis of peptides from myelin basic-protein binding to the MHC class-II protein, I-a(u), which confers susceptibility to experimental allergic encephalomyelitis. Mol. Med. 2:181.
23. Liu, G. Y., P. J. Fairchild, R. M. Smith, J. R. Prowle, D. Kioussis, and D. C. Wraith. 1995. Low avidity recognition of self-antigen by T cells permits escape from central tolerance. Immunity 3:407.
24. Wraith, D. C., D. E. Smilek, D. J. Mitchell, L. Steinman, and H. O. Mcdevitt. 1989. Antigen recognition in autoimmune encephalomyelitis and the potential for peptide-mediated immunotherapy. Cell 59:247.
25. Beech, J. T., T. Bainbridge, and S. J. Thompson. 1997. Incorporation of cells into an ELISA system enhances antigen-driven lymphokine detection. J. Immunol. Methods 205:163.
26. Inaba, K., M. Witmer-Pack, M. Inaba, K. S. Hathcock, H. Sakuta, M. Azuma, H. Yagita, K. Okumura, P. S. Linsley, S. Ikehara, et al. 1994. The tissue distribution of the B7-2 costimulator in mice: abundant expression on dendritic cells in situ and during maturation in vitro. J. Exp. Med. 180:1849.
27. Mueller, D. L., M. K. Jenkins, and R. H. Schwartz. 1989. Clonal expansion versus functional clonal inactivation: a costimulatory signalling pathway determines the outcome of T cell antigen receptor occupancy. Annu. Rev. Immunol. 7:445.
28. Mueller, D. L., M. K. Jenkins, and R. H. Schwartz. 1989. An accessory cell-derived costimulatory signal acts independently of protein kinase-c activation to allow T-cell proliferation and prevent the induction of unresponsiveness. J. Immunol. 142:2617.
29. Viola, A., and A. Lanzavecchia. 1996. T-cell activation determined by T-cell receptor number and tunable thresholds. Science 273:104.
30. Teh, H. S., and S. J. Teh. 1997. High concentrations of antigenic ligand activate and do not tolerize naive CD4 T cells in the absence of CD28/B7 costimulation. Cell. Immunol. 179:74.
31. Ferrick, D. A., M. D. Schrenzel, T. Mulvania, B. Hsieh, W. G. Ferlin, and W. Lepper. 1995. Differential production of interferon-gamma and interleukin-4 in response to Th1- and Th2-stimulating pathogens by γδ T cells in vivo. Nature 373:255.
32. Perrin, P. J., and M. K. Racke. 1997. Targeting B7:CD28 co-stimulation in the treatment of autoimmune demyelination. Drug News Perspect. 10:208.
33. Kamogawa, Y., L. A. E. Minasi, S. R. Carding, K. Bottomly, and R. A. Flavell. 1993. The relationship of IL-4- and IFN-γ-producing T cells studied by lineage ablation of IL-4-producing cells. Cell 75:985.
34. Hollsberg, P., C. Scholz, D. E. Anderson, E. A. Greenfield, V. K. Kuchroo, G. J. Freeman, and D. A. Hafler. 1997. Expression of a hypoglycosylated form of cd86 (b7-2) on human T cells with altered binding properties to CD28 and CTLA-4. J. Immunol. 159:4799.
35. Schmitz, J., A. Thiel, R. Kuhn, K. Rajewsky, W. Muller, M. Assenmacher, and A. Radbruch. 1994. Induction of interleukin-4 (IL-4) expression in T-helper (Th) cells is not dependent on IL-4 from non-Th cells. J. Exp. Med. 179:1349.
36. Scott, P. 1993. IL-12: initiation cytokine for cell-mediated-immunity. Science 260:496.
37. Greenwald, R. J., P. Lu, M. J. Halvorson, X. D. Zhou, S. J. Chen, K. B. Madden, P. J. Perrin, S. C. Morris, F. D. Finkelman, R. Peach, et al. 1997. Effects of blocking B7-1 and B7-2 interactions during a type 2 in vivo immune response. J. Immunol. 158:4088.
38. Tsuyuki, S., J. Tsuyuki, K. Einsle, M. Kopf, and A. J. Coyle. 1997. Costimulation through B7-2 (CD86) is required for the induction of a lung mucosal T helper cell 2 (TH2) immune response and altered airway responsiveness. J. Exp. Med. 185: 1671.
39. Rulifson, I. C., A. I. Sperling, P. E. Fields, F. W. Fitch, and J. A. Bluestone. 1997. 8D28 costimulation promotes the production of Th2 cytokines. J. Immunol. 158: 658.
40. Herold, K. C., V. Vezys, A. Koons, D. Lenschow, C. Thompson, and J. A. Bluestone. 1997. CD28/B7 costimulation regulates autoimmune diabetes induced with multiple low doses of streptozotocin. J. Immunol. 158:984.
41. Howard, F. D., P. Moingeon, U. Moebius, D. J. McConkey, B. Yandava, T. E. Gennert, and E. L. Reinherz. 1992. The CD3-zeta cytoplasmic domain mediates CD2-induced T-cell activation. J. Exp. Med. 176:139.
42. Biancone, L., G. Andres, H. Ahn, A. Lim, C. Dai, R. Noelle, H. Yagita, C. Demartino, and I. Stamenkovic. 1996. Distinct regulatory roles of lymphocyte costimulatory pathways on T-helper type 2-mediated autoimmune disease. J. Exp. Med. 183:1473.
43. Pfeiffer, C., J. Stein, S. Southwood, H. Ketelaar, A. Sette, and K. Bottomly. 1995. Altered peptide ligands can control CD4 T lymphocyte differentiation in vivo. J. Exp. Med. 181:1569.
44. + T cell responses: the alternative approaches. Annu. Rev. Immunol. 15:297.